Depression and Inflammation in Women with Breast Cancer: Risk and Resilience Factors

By sjmartinez • May 14, 2025

Korecki JRT, Slavich GM, Ganz PA, Irwin MR, Cole S, Crespi CM, Bower JE. Depression and Inflammation in Women with Breast Cancer: Risk and Resilience Factors. Biopsychosoc Sci Med. 2025 May 9. doi: 10.1097/PSY.0000000000001398. Epub ahead of print. PMID: 40359350.

Tags: and Energy study, BMI, body mass index, breast cancer survivors, C-reactive protein, CBT-I, Center for Epidemiological Studies Depression Scale, CES-D, CI, cognitive behavioral therapy for insomnia, confidence interval, CRP, depression, Hematology/Oncology, IL-6, Inflammation, interleukin, Life Orientation Test-Revised, lifetime stressor exposure, LOT-R, PA, physical activity, Pittsburgh Sleep Quality Index, PSQI, Publications, Research on Inflammation, resilience, RISE, SD, standard deviation, Strain, Stress, Stress and Adversity Inventory, TNF-α, Tumor necrosis factor-α

Related Posts

Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset

Nishio M, Seto T, Reck M, Garon EB, Nishio K, Kasahara K, Nishino K, Satouchi M, Yoh K, Hayashi H, Sakai K, Enatsu S, Frimodt-Møller[...]

Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy

Velez MA, Kang ES, Thompson CA, Lind-Lebuffe J, Shen C, Park SJ, Han A, Gower A, Li D, Rochigneux P, Grogan TR, Elashoff DA, Garon[...]

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, Molena D, Van Cutsem E, Hyung WJ, Wyrwicz L, Oh DY, Omori T, Moehler M, Garrido M,[...]